JOHN WOLF to Dermatologic Agents
This is a "connection" page, showing publications JOHN WOLF has written about Dermatologic Agents.
Connection Strength
0.943
-
Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis. Int J Dermatol. 2013 Sep; 52(9):1063-70.
Score: 0.402
-
Safety and tolerability in the MORE trial. Cutis. 2006 Jul; 78(1 Suppl):19-25.
Score: 0.245
-
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis. 2006 Apr; 77(4 Suppl):3-11.
Score: 0.240
-
Present and future rosacea therapy. Cutis. 2005 Mar; 75(3 Suppl):4-7; discussion 33-6.
Score: 0.056